DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Brivudine
Brivudine
The Protean Neurologic Manifestations of Varicella-Zoster Virus Infection
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene and Pathophysiological Conditions
Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning
New Zealand Data Sheet – Tradename (Active Ingredient)
PRODUCT INFORMATION Brivudine Item No
Silibinin Component for the Treatment of Hepatitis Silbininkomponente Zur Behandlung Von Hepatitis Composant De Silibinine Pour Le Traitement De L’Hépatite
Interactions with HBV Treatment
Surveillance of Antimicrobial Consumption in Europe 2013-2014 SURVEILLANCE REPORT
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
Swiss Recommendations for the Management of Varicella Zoster Virus Infections1
A Computational Approach to Aid Clinicians in Selecting Anti-Viral
WHO Pharmaceuticals Newsletter Provides You
Zāļu Patēriņa Statistika Statistics on Medicines Consumption
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
The Role of Ionic Liquids in the Pharmaceutical Field: an Overview of Relevant Applications
The Unknown Health Burden of Herpes Zoster Hospitalizations: the Effect on Chronic Disease Course in Adult Patients ≥50 Years
The Beneficial Effects of Varicella Zoster Virus
Advances and Perspectives in the Management of Varicella-Zoster Virus Infections
Top View
Repurposing of FDA Approved Drugs
WO 2013/167743 Al 14 November 2013 (14.11.2013) P O P C T
Drug Discovery of Nucleos(T)Ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80Th Birthday
Cytotoxic Effects of NF‑Κb Inhibitors in Combination with Anti‑Herpes Agents on Epstein‑Barr Virus‑Positive Gastric Carcinoma in Vitro
Antiherpetic Medication and Incident Dementia: Observational Cohort Studies in Four Countries
Patient Information Leaflet
Cas Cliniques Recommendations for VZV Management in Patients With
Zusammenstellung Von Monitoringdaten Zu Umweltkonzentrationen Von Arzneimitteln
Bovine Herpesvirus Type 1 As a Novel Oncolytic Virus
Approved Antiviral Drugs Over the Past 50 Years
Statistics on Medicines Consumption 2009
Atazanavir Sulfate/Cidofovir 867 Precautions Be 86% Bound to Serum Proteins
QRD Human Product Information Template
Signature Redacted Signature of Author: Department of Biology January 29, 2020
Summary of Product Characteristics
Structured Literature Review of Hepatic Toxicity Caused by Medicines
Study Protocol and Results
14-17 January 2019 PRAC Meeting Minutes
Aciclovir a Reappraisal of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy
The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus
Datasheet Inhibitors / Agonists / Screening Libraries a D RUG SCREEN in G EXPERT
(12) Patent Application Publication (10) Pub. No.: US 2016/0101219 A1 Jennings Et Al
Exploring the Selectivity of Guanine Scaffold in Anticancer Drug
Hspb1, Hspb5 and Hspb4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins
Varicella Zoster Virus Infections in Patients with Hemtologic
Ganciclovir Ophthalmic Gel 0.15% for the Treatment of Acute Herpetic Keratitis: Background, Effectiveness, Tolerability, Safety, and Future Applications
DBL™ Fluorouracil Injection BP
Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012